Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Argus Health
Cerilliant
UBS
Julphar
Teva
McKinsey
Harvard Business School
Express Scripts

Generated: May 27, 2018

DrugPatentWatch Database Preview

EPOPROSTENOL SODIUM Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Epoprostenol Sodium, and when can generic versions of Epoprostenol Sodium launch?

Epoprostenol Sodium is a drug marketed by Teva Pharms Usa and is included in one NDA.

The generic ingredient in EPOPROSTENOL SODIUM is epoprostenol sodium. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the epoprostenol sodium profile page.
Drug patent expirations by year for EPOPROSTENOL SODIUM
Pharmacology for EPOPROSTENOL SODIUM
Ingredient-typeProstaglandins I
Drug ClassProstacycline Vasodilator
Physiological EffectVasodilation
Medical Subject Heading (MeSH) Categories for EPOPROSTENOL SODIUM
Synonyms for EPOPROSTENOL SODIUM
(5E)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3R)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
(5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13E,8R,9S,11R,12R,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid sodium salt
(5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate
(5Z,9|A,11|A,13E,15S)-6,9-epoxy-11,15-Dihydroxy-prosta-5,13-dien-1-oic Acid Sodium Salt
(5Z,9alpha,11alpha,13E,15S)-11,15-dihydroxy-6,9-epoxyprosta-5,13-dien-1-oic acid
(5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid
(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[d]furan-2-ylidene]pentanoic acid
(5Z)-5-[(4R,5R)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
(Z)-(3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valeric acid
(Z)-5-((3aR,4R,5R,6aS)-5-hydroxy-4-((S,E)-3-hydroxyoct-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-ylidene)pentanoic acid
35121-78-9
4K04IQ1OF4
4UA76
5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
54231-EP2305653A1
54231-EP2308562A2
6,9-alpha-Epoxy-11-alpha,15(S)-dihydroxyprosta-5(Z),13(E)-dien-1-oic acid
6,9.alpha.-Epoxy-11.alpha.,15S-dihydroxyprosta-5Z,13E-dien-1-oic acid, monosodium salt
6,9S-epoxy-11R,15S-dihydoxy-5Z,13E-prostadienoic acid
61849-14-7
63748-50-5
63859-31-4
8222AH
88471-EP2272832A1
88471-EP2289518A1
88471-EP2292231A1
88471-EP2305260A1
88471-EP2305653A1
AC1NR00P
AC1O4BXH
AKOS024457370
BIDD:GT0514
BML1-F10
BRD-K64054020-001-02-7
BRN 1690090
BSPBio_001496
C20H31NaO5
C20H31O5.Na
CAS-61849-14-7
CHEBI:15552
CHEMBL1139
CHEMBL962
Cyclo-Prostin
D0V0IX
DCR9Z582X0
DSSTox_CID_26617
DSSTox_GSID_46617
DSSTox_RID_81769
DTXSID3046617
DTXSID5022988
EINECS 263-273-7
Epoprostanol
epoprostenol
Epoprostenol (USAN/INN)
Epoprostenol [USAN:INN]
Epoprostenol sodium [USAN:BAN]
Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer
Epoprostenolsodium
Epoprostenolum
Epoprostenolum [INN-Latin]
Flolan
Floran
GTPL1915
HMS1361K18
HMS1791K18
HMS1989K18
HMS3402K18
HMS3648L14
IDI1_033966
KAQKFAOMNZTLHT-OZUDYXHBSA-N
KB-IV-24
LMFA03010087
LMHIPJMTZHDKEW-XQYLJSSYSA-M
LS-176206
MolPort-006-132-470
NCGC00161285-01
NCGC00161285-02
NCGC00161285-03
NCGC00167427-01
PG-I2
PGI(sub 2)
PGI2
PGX
Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, (5Z,9alpha,11alpha,13E,15S)-
Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, sodium salt, (5Z,9alpha,11alpha,13E,15S)-
prostacyclin
Prostacyclin I2
Prostacyclin sodium
Prostacyclin sodium salt
Prostacycline
Prostacyclins
Prostaglandin 12
Prostaglandin I(2)
prostaglandin I2
PROSTAGLANDIN I2 Na
Prostaglandin I2 sodium
Prostaglandin X
Prostaglandin X sodium
ProstaglandinI
Prostaglandins X
SCHEMBL41344
SCHEMBL8041
SMP2_000227
Sodium (5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dien-1-oate
sodium (5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate
Sodium (Z)-(3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerate
Tox21_112431
TRY 200
Try-200
U 53,217
U 53,217A
U-53,217
U-53217
U-53217A
UNII-4K04IQ1OF4
UNII-DCR9Z582X0
V0155
Vasocyclin
ZINC3813078

US Patents and Regulatory Information for EPOPROSTENOL SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa EPOPROSTENOL SODIUM epoprostenol sodium INJECTABLE;INJECTION 078396-001 Apr 23, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Pharms Usa EPOPROSTENOL SODIUM epoprostenol sodium INJECTABLE;INJECTION 078396-002 Apr 23, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Citi
US Army
Baxter
Harvard Business School
Cerilliant
McKesson
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.